Plasma Cell-free Epstein-Barr Virus DNA Quantitation in Patients with Nasopharyngeal Carcinoma: Correlation with Clinical Staging
โ Scribed by Y. M. D. LO; S. F. LEUNG; L. Y. S. CHAN; K. W. LO; J. ZHANG; A. T. C. CHAN; J. C. K. LEE; N. M. HJELM; P. J. JOHNSON; D. P. HUANG
- Book ID
- 111396484
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 842 KB
- Volume
- 906
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background. The quantity of circulating cellโfree EpsteinโBarr virus (EBV) DNA in patients with nasopharyngeal carcinoma (NPC) managed by radiotherapy has prognostic relevance. We measured the copy number of EBV DNA in patients with early recurrent NPC before and after salvage nasop
A salt-dependent DNA polymerase activity was demonstrated in the culture of an EBV-producing, lymphoblastoid cell line (NPC-204 cells) treated with 5-iodo-2'-deoxyuridine (IUdR). There was a high frequency of levels of antibody to this enzyme in sera of patients with nasopharyngeal carcinoma (NPC).